TCHP and COVID-19: If, as in silico, the S2 subunit of spike interacts with tumor suppressor proteins in vivo, such a demonstration would have implications not only for the long-term health of those impacted by COVID-19 but also of those who received COVID-19 vaccination and repeated booster doses.